Cancer Research UK logo.
SearchDonate
  • Search

A study looking at radiotherapy with carbogen and nicotinamide for prostate cancer (PROCON)

Overview

Cancer types:

Prostate cancer

Status:

Results

Phase:

Phase 1/2

Details

This study looked at using carbogen and nicotinamide during radiotherapy for prostate cancer.

The study was open for people to join between 2011 and 2013. The team presented the results at a conference in 2020.

Recruitment start: 15 December 2011

Recruitment end: 30 September 2013

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Roberto Alonzi

Supported by

East and North Hertfordshire NHS Trust

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Prostate Cancer UK

Last reviewed: 12 September 2022

CRUK internal database number: 7670

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.